在对健康和典型饮食模式的随机交叉试验中,代谢分析和饮食质量评分
Jordan Stanford1,2,3, María Gómez-Martín1,2,3, Erin Drury Clarke1,2,3
1School of Health Sciences, College of Health Medicine and Wellbeing, The University of Newcastle, New South Wales, Australia.
Molecular nutrition & food research
|October 1, 2025
概括
确定了健康澳大利亚饮食 (HAD) 的客观代谢生物标志物,显示了心脏代谢健康标志物的显著改善. 这些发现支持使用代谢学来评估饮食质量和风险监测.
科学领域:
- 营养科学 营养科学
- 代谢学 代谢学 代谢学
- 心血管健康 心血管健康
背景情况:
- 饮食模式显著影响心脏代谢健康.
- 需要客观的生物标志物来评估遵守饮食指南.
- 通过代谢学来区分健康饮食和典型饮食仍然是一个研究领域.
研究的目的:
- 确定客观的代谢生物标志物,使健康的澳大利亚饮食 (HAD) 与典型的澳大利亚饮食 (TAD) 区别开来.
- 评估这些代谢生物标志物和心脏代谢健康指标之间的关系.
主要方法:
- 在34名健康成年人中进行了一项为期2周的随机交叉养试验,比较了HAD和TAD.
- 使用UHPLC-MS/MS.进行血和尿液代谢分析.
- 弹性净回归用于识别歧视性代谢物并导出复合生物标志物得分.
主要成果:
- 65种区分代谢物 (31种血,34种尿液) 区分了HAD和TAD.
- 综合饮食质量生物标记得分与改善的血压,LDL胆固醇,甘油三和禁食葡萄糖显著相关.
- 观察到HAD的明显的短期代谢特征.
结论:
- 客观的代谢生物标志物可以区分健康和典型的饮食模式.
- 鉴定的生物标志物和综合评分显示出评估饮食质量和心脏代谢风险的潜力.
- 对于临床翻译,需要在独立队列中进行进一步的验证.
相关概念视频
Bioavailability Study Design: Healthy Subjects Versus Patients
144
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144
Crossover Experiments
4.5K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.5K
Bioavailability Study Design: Absolute Versus Relative Bioavailability
301
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
301


